META
Meta Platforms, Inc.
META's fundamentals are mixed, but it looks cheap: trading at 21x earnings, below its usual 27x. Analysts expect earnings growth, though they disagree widely on how much.
VEON
VEON Ltd.
There isn't enough reported data to score VEON yet.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
VEON Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Healthy |
VEON's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META has the edge over VEON in the historical PE scenario, which offers more potential upside but is not a forecast.
VEON PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.5x | $63.62 | -15% |
| Fair | 8.5x | $83.40 | +11% |
| Current | 9.8x | $75.15 | — |
| Expensive | 10x | $103 | +37% |
Historical ranges are pointers, not guarantees.
VEON's PE is 9.8x, but its earnings don't support one, so it isn't a reliable read right now.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
VEON Forward outlook
There aren't enough analyst estimates for VEON to show an outlook.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META earned $29.32 per share over the past year, up 30% from the year before.
VEON Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $9.82 | +409% |
| Q2 2025 | $10.07 | +$10.08 |
| Q1 2025 | $2.53 | -2.3% |
| Q4 2024 | $1.93 | -71% |
| Q4 2023 | $6.67 | +$8.92 |
| Q4 2022 | -$2.25 | -123% |
| Q4 2021 | $9.75 | +$14.73 |
| Q4 2020 | -$4.98 | -155% |
VEON has the edge over META in the latest year-over-year earnings comparison.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META's revenue has grown year over year for 15 quarters in a row: $64.6B last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META's operating margin was 20% last quarter, down 20 points from the same quarter a year ago, near the bottom of its range since 2019.
VEON Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $2.3B | +12% |
| Q2 2025 | $1.1B | +5.8% |
| Q1 2025 | $1B | +8.9% |
| Q4 2024 | $2B | +7.2% |
| Q2 2024 | $1B | +12% |
| Q1 2024 | $942M | +6.6% |
| Q4 2023 | $1.9B | -49% |
| Q4 2022 | $3.8B | -52% |
VEON has the edge over META in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 17% | -10 points |
| Q2 2025 | 75% | +54 points |
| Q1 2025 | 23% | -2.1 points |
| Q4 2024 | 31% | +4.6 points |
| Q2 2024 | 27% | +3.9 points |
| Q1 2024 | 21% | -9.6 points |
| Q4 2023 | 25% | +5.6 points |
| Q2 2023 | 26% | +29 points |
VEON's operating margin was 17% last quarter, down 10 points from the same quarter a year ago.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $28.6B over the past year.
VEON Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $408M | +3.6% |
| Q2 2025 | -$48M | -167% |
| Q1 2025 | $255M | +410% |
| Q4 2024 | $394M | -17% |
| Q2 2024 | $72M | -78% |
| Q1 2024 | $50M | -86% |
| Q4 2023 | $476M | +59% |
| Q4 2022 | $299M | -48% |
VEON still generates free cash flow, though less than at its 2016 peak: $1B over the past year.
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has the edge over VEON on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
VEON Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2459% | +1.7B shares |
| 1 year | +2439% | +1.7B shares |
| 3 years | +2488% | +1.7B shares |
| 5 years | +2464% | +1.7B shares |
| Available history | +2464% | +1.7B shares |
VEON has 1.8B diluted shares, up 2439% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $37M |
| Q2 2025 | $44M |
| Q1 2025 | $24M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q2 2020 | — |
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
VEON Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 0.8x | Very low |
| Q2 2025 | 1.9x | Healthy |
| Q1 2025 | 1.6x | Healthy |
| Q4 2024 | 0.9x | Very low |
| Q2 2024 | 2.1x | Moderate |
| Q1 2024 | 2.0x | Moderate |
| Q4 2023 | 1.1x | Healthy |
| Q4 2022 | 1.8x | Healthy |
VEON's net debt is less than a year of its operating earnings (EBITDA), down from 2.0 years a year ago.
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
VEON Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.7 | Neutral |
| Stochastic | 70.6 | Neutral |
VEON's weekly RSI is 65 (neutral) and its Stochastic is 71 (neutral).
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
VEON PE vs Communication Services Sector
| Metric | VEON | Sector median | Relative |
|---|---|---|---|
| PE | 9.8x | 16x | 41% below |
| PE % | 77 | 26 | 51 pts above |
VEON has the edge over META on valuation relative to its sector.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
VEON Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $78.4 | 4.2% below |
| 20 week MA | $66.1 | 14% above |
| 50 week MA | $57.9 | 30% above |
| 100 week MA | $52.9 | 42% above |
| 200 week MA | $37.7 | 100% above |
VEON has the edge over META on trend strength, trading above more of its moving averages.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META's yearly returns have swung widely, from +200% in 2023 to −65% in 2022. It's down 6% so far in 2026.
VEON Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $63.3 | $40.3 | -36% |
| 2021 | $40.3 | $41.8 | +3.7% |
| 2022 | $41.8 | $11.5 | -72% |
| 2023 | $11.5 | $19.7 | +71% |
| 2024 | $19.7 | $39.0 | +98% |
| 2025 | $39.0 | $52.7 | +35% |
| 2026 YTD | $52.7 | $75.2 | +43% |
VEON has the edge over META on returns for 2026, with the stronger performance.